ClinicalTrials.gov
public full text
Public Domain
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall health-related quality of life (HRQoL) experienced by Immunoglobulin A nephropathy (IgAN) patients and their caregivers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy#1138972
- An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL#876683
- Global burden and health inequalities of acute glomerulonephritis from 1990 to 2021: a systematic analysis of global burden disease study 2021#337989
- Evaluating the reliability and quality of lupus nephritis educational content on TikTok and Bilibili: a cross-sectional content analysis.#1080819
- A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)#1111566
Record · ID 894738
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive